A Phase III, Single-Center, Randomized Controlled Trial Comparing Clinical and Cost-Effectiveness Analyses of Botulinum Toxin Uterine Injections Versus Placebo for Severe Dysmenorrhea and Chronic Pelvic Pain of Uterine Origin After Standard Therapeutic Failure. (July 2022) - Levêque, Christine; Bautrant, Eric; Santos, Melina; Kouame, Jean Martial; Franké, Oona; Amiel, Christophe; Bensousan, Thierry; Thiers-Bautrant, Dominique; Siani, Carole